Earnings calendar/INDV
Indivior Pharmaceuticals Inc (INDV)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$1.06
Street estimate
Revenue target
$329.4M
Street estimate
Trailing EPS (avg 4Q)
$0.91
Beat rate last 4: 100%
Latest EPS YoY
+125.5%
vs 2025-07-31
Latest revenue YoY
+13.6%
How results look so far
Trailing revenue (avg 4Q)
$333.0M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS beat
EPS actual / est
$1.15 / $0.87
+32.3%
Revenue actual / est
$343.0M / $306.2M
+12.0%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $1.06 | Pending | — | $329.4M | Pending | — |
| 8/3/2026 | $0.87 | $1.15 | +32.3% | $306.2M | $343.0M | +12.0% |
| 7/30/2026upcoming | $0.89 | Pending | — | $307.6M | Pending | — |
| 4/30/2026 | $0.64 | $0.96 | +50.0% | $272.8M | $317.0M | +16.2% |
| 4/23/2026upcoming | $0.64 | Pending | — | $272.6M | Pending | — |
| 2/26/2026 | $0.65 | $0.82 | +26.2% | $305.6M | $358.0M | +17.1% |
| 2/19/2026upcoming | $0.65 | Pending | — | — | Pending | — |
| 10/30/2025 | $0.38 | $0.72 | +89.5% | $306.2M | $314.0M | +2.5% |
| 7/31/2025 | $0.26 | $0.51 | +96.2% | $255.2M | $302.0M | +18.3% |
| 4/24/2025 | $0.22 | $0.41 | +86.4% | $242.3M | $266.0M | +9.8% |
| 2/20/2025 | $0.32 | $0.32 | 0.0% | $240.1M | $299.0M | +24.5% |
| 10/24/2024 | $0.31 | $0.54 | +74.2% | $260.4M | $307.0M | +17.9% |
| 7/25/2024 | $0.40 | $0.44 | +10.0% | $289.4M | $299.6M | +3.5% |
| 4/25/2024 | $0.42 | $0.37 | -11.9% | $299.8M | $282.7M | -5.7% |
| 2/22/2024 | $0.28 | $0.43 | +53.6% | $276.0M | $300.7M | +8.9% |
| 11/9/2023 | $0.30 | $0.34 | +13.3% | $270.5M | $261.2M | -3.4% |
| 7/27/2023 | $0.22 | $0.39 | +77.3% | $255.0M | $279.8M | +9.7% |
| 4/27/2023 | — | $0.40 | — | $302.7M | $256.8M | -15.2% |
| 2/16/2023 | — | $0.27 | — | $223.0M | $241.0M | +8.1% |
| 12/30/2022 | — | $-1.38 | — | $223.0M | $249.5M | +11.9% |
| 10/27/2022 | — | $0.29 | — | $217.0M | $232.0M | +6.9% |
| 9/29/2022 | — | $0.27 | — | $217.0M | $220.2M | +1.5% |
| 7/28/2022 | — | $0.30 | — | $219.0M | $221.0M | +0.9% |
| 6/29/2022 | — | $0.33 | — | — | $214.4M | — |
| 3/30/2022 | — | $0.27 | — | $219.0M | $202.7M | -7.4% |
| 12/30/2021 | — | $0.25 | — | — | $222.7M | — |